Complex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP.
Swati SinghGabriela Bernal AstrainAna Maria HincapieMarilyn GoudreaultMatthew J SmithPublished in: EMBO reports (2024)
RAS GTPases bind effectors to convert upstream cues to changes in cellular function. Effectors of classical H/K/NRAS are defined by RBD/RA domains which recognize the GTP-bound conformation of these GTPases, yet the specificity of RBD/RAs for over 160 RAS superfamily proteins remains poorly explored. We have systematically mapped interactions between BRAF and four RASSF effectors, the largest family of RA-containing proteins, with all RAS, RHO and ARF small GTPases. 39 validated complexes reveal plasticity in RASSF binding, while BRAF demonstrates tight specificity for classical H/K/NRAS. Complex between RASSF5 and diverse RAS GTPases at the plasma membrane can activate Hippo signalling and sequester YAP in the cytosol. RASSF8 undergoes liquid-liquid phase separation and resides in YAP-associated membraneless condensates, which also engage several RAS and RHO GTPases. The poorly studied RASSF3 has been identified as a first potential effector of mitochondrial MIRO proteins, and its co-expression with these GTPases impacts mitochondria and peroxisome distribution. These data reveal the complex nature of GTPase-effector interactions and show their systematic elucidation can reveal completely novel and biologically relevant cellular processes.
Keyphrases
- wild type
- type iii
- rheumatoid arthritis
- genome wide
- single cell
- oxidative stress
- dna methylation
- gene expression
- immune response
- ankylosing spondylitis
- climate change
- cell death
- risk assessment
- transcription factor
- systemic lupus erythematosus
- systemic sclerosis
- dna binding
- interstitial lung disease
- artificial intelligence
- crystal structure